Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients
- 1 May 1997
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 16 (5), 364-368
- https://doi.org/10.1007/bf01726364
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patientsAnnals of Hematology, 1995
- Comparison of Imipenem versus Cefuroxim Plus Tobramycin as Empirical Therapy for Febrile Granulocytopenic Patients and Efficacy of Vancomycin and Aztreonam in case of FailureScandinavian Journal of Infectious Diseases, 1994
- Fungal infections in cancer patients: An international autopsy surveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- A Pilot Study of Prophylactic Aerosolized Amphotericin B In Patients at Risk for Prolonged NeutropeniaLeukemia & Lymphoma, 1992
- Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill.Thorax, 1990
- Empiric antifungal therapy in febrile granulocytopenic patientsAmerican Journal Of Medicine, 1989
- Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosisAntimicrobial Agents and Chemotherapy, 1988
- Amphotericin B Nasal Spray as Prophylaxis against Aspergillosis in Patients with NeutropeniaNew England Journal of Medicine, 1984